BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31704152)

  • 1. Expression and significance of ETFDH in hepatocellular carcinoma.
    Wu Y; Zhang X; Shen R; Huang J; Lu X; Zheng G; Chen X
    Pathol Res Pract; 2019 Dec; 215(12):152702. PubMed ID: 31704152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Law LK; Tang NL; Hui J; Fung SL; Ruiter J; Wanders RJ; Fok TF; Lam CW
    Clin Chim Acta; 2009 Jun; 404(2):95-9. PubMed ID: 19265687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Missaglia S; Tavian D; Moro L; Angelini C
    Lipids Health Dis; 2018 Nov; 17(1):254. PubMed ID: 30424791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased muscle coenzyme Q10 in riboflavin responsive MADD with ETFDH gene mutations due to secondary mitochondrial proliferation.
    Wen B; Li D; Shan J; Liu S; Li W; Zhao Y; Lin P; Zheng J; Li D; Gong Y; Yan C
    Mol Genet Metab; 2013 Jun; 109(2):154-60. PubMed ID: 23628458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G>A.
    Wang ZQ; Chen XJ; Murong SX; Wang N; Wu ZY
    J Mol Med (Berl); 2011 Jun; 89(6):569-76. PubMed ID: 21347544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel ETFDH mutation in an adult patient with late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Chen M; Peng J; Wei W; Wang R; Xu H; Liu H
    Int J Neurosci; 2018 Mar; 128(3):291-294. PubMed ID: 28914566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High resolution melting analysis facilitates mutation screening of ETFDH gene: applications in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Er TK; Liang WC; Chang JG; Jong YJ
    Clin Chim Acta; 2010 May; 411(9-10):690-9. PubMed ID: 20138856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.
    Fu HX; Liu XY; Wang ZQ; Jin M; Wang DN; He JJ; Lin MT; Wang N
    Neurol Sci; 2016 Jul; 37(7):1099-105. PubMed ID: 27000805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETFDH Mutations and Flavin Adenine Dinucleotide Homeostasis Disturbance Are Essential for Developing Riboflavin-Responsive Multiple Acyl-Coenzyme A Dehydrogenation Deficiency.
    Xu J; Li D; Lv J; Xu X; Wen B; Lin P; Liu F; Ji K; Shan J; Li H; Li W; Zhao Y; Zhao D; Pok JY; Yan C
    Ann Neurol; 2018 Nov; 84(5):659-673. PubMed ID: 30232818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel electron transfer flavoprotein dehydrogenase (ETFDH) gene mutation identified in a newborn with glutaric acidemia type II: a case report of a Chinese family.
    Ou M; Zhu L; Zhang Y; Zhang Y; Zhou J; Zhang Y; Chen X; Yang L; Li T; Su X; Hu Q; Wang W
    BMC Med Genet; 2020 May; 21(1):98. PubMed ID: 32393189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma.
    Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L
    Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency.
    Olsen RK; Andresen BS; Christensen E; Bross P; Skovby F; Gregersen N
    Hum Mutat; 2003 Jul; 22(1):12-23. PubMed ID: 12815589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.
    Tanaka K; Tomita H; Hisamatsu K; Nakashima T; Hatano Y; Sasaki Y; Osada S; Tanaka T; Miyazaki T; Yoshida K; Hara A
    Oncotarget; 2015 Sep; 6(28):24722-32. PubMed ID: 26160842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report.
    Goh LL; Lee Y; Tan ES; Lim JSC; Lim CW; Dalan R
    BMC Med Genomics; 2018 Apr; 11(1):37. PubMed ID: 29615056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of inositol polyphosphate phosphatase-like 1 associates with unfavorable survival in hepatocellular carcinoma.
    Fu M; Gu X; Ni H; Zhang W; Chang F; Gong L; Chen X; Li J; Qiu L; Shi C; Bao J
    Int J Clin Exp Pathol; 2013; 6(11):2515-22. PubMed ID: 24228114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.
    Olsen RK; Olpin SE; Andresen BS; Miedzybrodzka ZH; Pourfarzam M; Merinero B; Frerman FE; Beresford MW; Dean JC; Cornelius N; Andersen O; Oldfors A; Holme E; Gregersen N; Turnbull DM; Morris AA
    Brain; 2007 Aug; 130(Pt 8):2045-54. PubMed ID: 17584774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ETFDH c.158A>G variation disrupts the balanced interplay of ESE- and ESS-binding proteins thereby causing missplicing and multiple Acyl-CoA dehydrogenation deficiency.
    Olsen RK; Brøner S; Sabaratnam R; Doktor TK; Andersen HS; Bruun GH; Gahrn B; Stenbroen V; Olpin SE; Dobbie A; Gregersen N; Andresen BS
    Hum Mutat; 2014 Jan; 35(1):86-95. PubMed ID: 24123825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coenzyme Q10 serves to couple mitochondrial oxidative phosphorylation and fatty acid β-oxidation, and attenuates NLRP3 inflammasome activation.
    Chokchaiwong S; Kuo YT; Lin SH; Hsu YC; Hsu SP; Liu YT; Chou AJ; Kao SH
    Free Radic Res; 2018 Dec; 52(11-12):1445-1455. PubMed ID: 30003820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
    Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
    Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.